M E Billingham

3.6k total citations · 2 hit papers
52 papers, 2.8k citations indexed

About

M E Billingham is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, M E Billingham has authored 52 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 17 papers in Transplantation. Recurrent topics in M E Billingham's work include Transplantation: Methods and Outcomes (27 papers), Viral Infections and Immunology Research (14 papers) and Renal Transplantation Outcomes and Treatments (12 papers). M E Billingham is often cited by papers focused on Transplantation: Methods and Outcomes (27 papers), Viral Infections and Immunology Research (14 papers) and Renal Transplantation Outcomes and Treatments (12 papers). M E Billingham collaborates with scholars based in United States, Switzerland and United Kingdom. M E Billingham's co-authors include Reed A. Rowan, Alan H. Singer, P Zera, John P. Cooke, Philip S. Tsao, Craig R. Smith, Tim Higenbottam, Marshall I. Hertz, Jonathan D. Cooper and Thomas M. Egan and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

M E Billingham

51 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

1993 604 citations Jonathan D. Cooper, M E Billingham et al. PubMed profile →
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

1992 565 citations John P. Cooke, Alan H. Singer et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M E Billingham United States	22	1.5k	1.2k	419	413	405	52	2.8k
Ariela Pomerance United Kingdom	31	841 0.6×	1.9k 1.6×	305 0.7×	570 1.4×	119 0.3×	72	3.2k
Robert Jan van Suylen Netherlands	34	712 0.5×	602 0.5×	301 0.7×	1.3k 3.2×	133 0.3×	75	3.1k
A Herskowitz United States	21	541 0.4×	1.5k 1.3×	127 0.3×	90 0.2×	99 0.2×	43	2.4k
Aldo Dobrina Italy	29	624 0.4×	804 0.7×	313 0.7×	181 0.4×	44 0.1×	61	3.1k
Hamid Rabb United States	31	830 0.6×	129 0.1×	312 0.7×	350 0.8×	784 1.9×	65	3.2k
Andrew Mitchell United Kingdom	24	937 0.6×	913 0.8×	70 0.2×	249 0.6×	159 0.4×	66	1.6k
B.K. Shenton United Kingdom	26	944 0.6×	99 0.1×	154 0.4×	324 0.8×	482 1.2×	123	2.5k
Dani S. Zander United States	34	618 0.4×	135 0.1×	192 0.5×	1.0k 2.4×	118 0.3×	90	2.9k
Satoshi Yamamoto Japan	33	1.6k 1.1×	242 0.2×	119 0.3×	1.0k 2.4×	43 0.1×	252	4.0k
William P. Duguid Canada	25	1.4k 0.9×	793 0.7×	583 1.4×	1.4k 3.3×	23 0.1×	61	4.0k

Countries citing papers authored by M E Billingham

Since Specialization

Citations

This map shows the geographic impact of M E Billingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M E Billingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M E Billingham more than expected).

Fields of papers citing papers by M E Billingham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M E Billingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M E Billingham. The network helps show where M E Billingham may publish in the future.

Co-authorship network of co-authors of M E Billingham

This figure shows the co-authorship network connecting the top 25 collaborators of M E Billingham. A scholar is included among the top collaborators of M E Billingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M E Billingham. M E Billingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gummert, Jan, M.J. Barten, Carolin Decker, et al.. (1999). The IMPDH inhibitor VX-497 is the first rationally synthesized immunosuppressant to prolong allograft survival. Transplantation. 67(7). S62–S62. 2 indexed citations

Gummert, Jan, et al.. (1999). Therapeutic monitoring of mycophenolic acid (MPA): Assays of immune function in peripheral blood predict efficacy for inhibition of histologic graft rejection. The Journal of Heart and Lung Transplantation. 18(1). 53–54. 11 indexed citations

Gummert, Jan, Tuija Ikonen, Norman Briffa, et al.. (1998). A new large-animal model for research of graft vascular disease. Transplantation Proceedings. 30(8). 4023–4023. 5 indexed citations

Sarris, George E., Julian A. Smith, N E Shumway, et al.. (1995). Long-term results of combined heart-lung transplantation: the Stanford experience.. PubMed. 13(6). 940–9. 46 indexed citations

Meiser, Bruno M., K Wenke, Joachim Thiery, et al.. (1993). Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.. PubMed. 25(2). 2077–9. 31 indexed citations

Cooper, Jonathan D., M E Billingham, Thomas M. Egan, et al.. (1993). A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.. PubMed. 12(5). 713–6. 604 indexed citations breakdown →

Gregory, Clare R., et al.. (1993). Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.. PubMed. 25(1 Pt 1). 120–1. 9 indexed citations

Weiss, Lawrence M., et al.. (1992). Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues.. Journal of Clinical Investigation. 90(1). 156–159. 56 indexed citations

Cooke, John P., Alan H. Singer, Philip S. Tsao, et al.. (1992). Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.. Journal of Clinical Investigation. 90(3). 1168–1172. 565 indexed citations breakdown →

10.

Hunt, Sharon & M E Billingham. (1991). Long-Term Results of Cardiac Transplantation. Annual Review of Medicine. 42(1). 437–447. 23 indexed citations

11.

Meiser, Bruno M., Randall E. Morris, & M E Billingham. (1991). Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. The Lancet. 338(8778). 1297–1298. 106 indexed citations

12.

Billingham, M E. (1989). Pathology of the Heart and Great Vessels. The American Journal of Surgical Pathology. 13(11). 993–993.

13.

Prop, J, et al.. (1988). AIRWAY PATHOLOGY IN THE TRANSPLANTED RAT LUNG. University of Groningen research database (University of Groningen / Centre for Information Technology). 1 indexed citations

14.

Rowan, Reed A., Anna Masek, & M E Billingham. (1988). Ultrastructural morphometric analysis of endomyocardial biopsies. Idiopathic dilated cardiomyopathy, anthracycline cardiotoxicity, and normal myocardium.. PubMed. 2(2). 137–44. 20 indexed citations

15.

Lurie, Keith G., Michael R. Bristow, Wayne Minobe, Anna Masek, & M E Billingham. (1988). 6-Hydroxydopamine mediated cardiotoxicity in rabbits.. PubMed. 2(2). 181–91. 11 indexed citations

16.

Baldwin, John C., P E Oyer, Edward B. Stinson, et al.. (1988). Comparison of cardiac rejection in heart and heart-lung transplantation.. PubMed. 6(6). 352–6. 21 indexed citations

17.

Shanes, Jeffrey G., Jalal K. Ghali, M E Billingham, et al.. (1987). Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.. Circulation. 75(2). 401–405. 161 indexed citations

18.

Tucker, C., et al.. (1985). A new method for assessing right-sided heart pressures using encapsulated microbubbles--a preliminary report.. PubMed. 143(4). 463–8. 6 indexed citations

19.

Schindera, F, et al.. (1977). Polymeric albumin in the urine of patients with nephrotic syndrome.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8(3). 395–9. 10 indexed citations

20.

Billingham, M E, et al.. (1974). SERIAL TRANSVENOUS BIOPSY OF THE TRANSPLANTED HUMAN HEART IMPROVED MANAGEMENT OF ACUTE REJECTION EPISODES. The Lancet. 303(7862). 821–826. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact